Adrianna Rowe1,2, Andrew Chang3, Emily Lostchuck3, Kathleen Lin4, Frank Scheuermeyer3,5, Victoria McCann6, Jane Buxton7,8, Jessica Moe3,7,9, Raymond Cho10, Paul Clerc3, Connor McSweeney4, Andy Jiang11, Roy Purssell3,9,12. 1. Department of Emergency Medicine, University Health Network, ON, Toronto, Canada. arowe.md@gmail.com. 2. Division of Clinical Pharmacology and Toxicology, Department of Medicine, University of Toronto, Toronto, ON, Canada. arowe.md@gmail.com. 3. Department of Emergency Medicine, University of British Columbia, Vancouver, BC, Canada. 4. Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. 5. Department of Emergency Medicine, St. Paul's Hospital, Vancouver, BC, Canada. 6. Faculty of Medicine, Queen's University, Kingston, ON, Canada. 7. British Columbia Centre for Disease Control, Vancouver, BC, Canada. 8. School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada. 9. Department of Emergency Medicine, Vancouver General Hospital, Vancouver, BC, Canada. 10. Department of Family and Community Medicine, University of Toronto, Toronto, ON, Canada. 11. Department of Internal Medicine, University of Western Ontario, London, ON, Canada. 12. British Columbia Drug and Poison Information Centre, Vancouver, BC, Canada.
Abstract
OBJECTIVES: There are conflicting recommendations for lay rescuer management of patients who are unresponsive and apneic due to opioid overdose. We evaluated the management of such patients at an urban supervised consumption site. METHODS: At a single urban supervised consumption site in Vancouver, BC, we conducted a retrospective chart review and administrative database linkage of consecutive patients who were unresponsive and apneic following witnessed opioid overdose between January 1, 2012 and December 31, 2017. We linked these visits with regional hospital records to define the entire care episode, which concluded when the patient was discharged from the supervised consumption site, ED, or hospital, or died. The primary outcome was successful resuscitation, defined as alive and neurologically intact (ambulatory and speaking coherently, or alert and oriented, or Glasgow Coma Scale 15) at the conclusion of the care episode. Secondary outcomes included mortality and predefined complications of resuscitation. RESULTS: We collected 767 patients, with a median age of 43 and 81.6% male, with complete follow-up on 763 patients (99.5%). All patients were managed with oxygen and ventilation (100%, 95% CI 0.995-1.0); 715 (93.2%, 95% CI 0.911-0.949) received naloxone; no patients underwent chest compressions (0%, 95% CI 0-0.005). All patients with complete follow-up were alive and neurologically intact at the end of their care episode (100%, 95% CI 0.994-1.0). Overall, 191 (24.9%) patients were transported to hospital, and 15 (2.0%) patients required additional naloxone after leaving the supervised consumption site; 16 (2.1%) developed complications, and 1 patient was admitted to hospital. CONCLUSIONS: At an urban supervised consumption site, all unresponsive, apneic patients with witnessed opioid overdose were successfully resuscitated with oxygen and/or naloxone. No patients required chest compressions.
OBJECTIVES: There are conflicting recommendations for lay rescuer management of patients who are unresponsive and apneic due to opioid overdose. We evaluated the management of such patients at an urban supervised consumption site. METHODS: At a single urban supervised consumption site in Vancouver, BC, we conducted a retrospective chart review and administrative database linkage of consecutive patients who were unresponsive and apneic following witnessed opioid overdose between January 1, 2012 and December 31, 2017. We linked these visits with regional hospital records to define the entire care episode, which concluded when the patient was discharged from the supervised consumption site, ED, or hospital, or died. The primary outcome was successful resuscitation, defined as alive and neurologically intact (ambulatory and speaking coherently, or alert and oriented, or Glasgow Coma Scale 15) at the conclusion of the care episode. Secondary outcomes included mortality and predefined complications of resuscitation. RESULTS: We collected 767 patients, with a median age of 43 and 81.6% male, with complete follow-up on 763 patients (99.5%). All patients were managed with oxygen and ventilation (100%, 95% CI 0.995-1.0); 715 (93.2%, 95% CI 0.911-0.949) received naloxone; no patients underwent chest compressions (0%, 95% CI 0-0.005). All patients with complete follow-up were alive and neurologically intact at the end of their care episode (100%, 95% CI 0.994-1.0). Overall, 191 (24.9%) patients were transported to hospital, and 15 (2.0%) patients required additional naloxone after leaving the supervised consumption site; 16 (2.1%) developed complications, and 1 patient was admitted to hospital. CONCLUSIONS: At an urban supervised consumption site, all unresponsive, apneic patients with witnessed opioid overdose were successfully resuscitated with oxygen and/or naloxone. No patients required chest compressions.
Authors: Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde Journal: J Biomed Inform Date: 2008-09-30 Impact factor: 6.317
Authors: Takahisa Kawano; Brian Grunau; Frank X Scheuermeyer; Takahisa Kawano; Brian Grunau; Frank X Scheuermeyer; Brian Grunau; Koichiro Gibo Journal: Ann Emerg Med Date: 2018-08 Impact factor: 5.721
Authors: Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda Journal: J Biomed Inform Date: 2019-05-09 Impact factor: 6.317
Authors: Cameron Dezfulian; Aaron M Orkin; Bradley A Maron; Jonathan Elmer; Saket Girotra; Mark T Gladwin; Raina M Merchant; Ashish R Panchal; Sarah M Perman; Monique Anderson Starks; Sean van Diepen; Eric J Lavonas Journal: Circulation Date: 2021-03-08 Impact factor: 29.690